ID: ALA1160307

Max Phase: Preclinical

Molecular Formula: C7H8FO3P

Molecular Weight: 190.11

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=P(O)(O)[C@@H](F)c1ccccc1

Standard InChI:  InChI=1S/C7H8FO3P/c8-7(12(9,10)11)6-4-2-1-3-5-6/h1-5,7H,(H2,9,10,11)/t7-/m1/s1

Standard InChI Key:  PLXHCOZOUVXCTI-SSDOTTSWSA-N

Associated Targets(non-human)

Mandelate racemase 27 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 190.11Molecular Weight (Monoisotopic): 190.0195AlogP: 1.83#Rotatable Bonds: 2
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 1HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.12CX Basic pKa: CX LogP: 1.05CX LogD: -1.42
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.70Np Likeness Score: -0.17

References

1. St Maurice M, Bearne SL, Lu W, Taylor SD..  (2003)  Inhibition of mandelate racemase by alpha-fluorobenzylphosphonates.,  13  (12): [PMID:12781191] [10.1016/s0960-894x(03)00311-1]

Source